−2.78USD
−76.40 MUSD
8.15 M
About Xilio Therapeutics, Inc.
Sector
CEO
René Russo
Headquarters
Waltham
Website
Employees (FY)
73
Founded
2015
ISIN
US98422T1007
FIGI
BBG00M4D4X92
Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on harnessing the immune system to achieve deep and durable clinical responses in cancer. The company uses its proprietary geographically precise solutions platform to rapidly engineer novel molecules, including cytokines and other biologics. Xilio Therapeutics was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of XLO is 1.28 USD — it has increased by 4.07% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Xilio Therapeutics, Inc. stocks are traded under the ticker XLO.
Xilio Therapeutics, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
XLO stock is 6.67% volatile and has beta coefficient of −0.85. Check out the list of the most volatile stocks — is Xilio Therapeutics, Inc. there?
One year price forecast for Xilio Therapeutics, Inc. has a max estimate of 6.00 USD and a min estimate of 5.00 USD.
XLO earnings for the last quarter are −0.61 USD whereas the estimation was −0.81 USD which accounts for 24.46% surprise. Estimated earnings for the next quarter are −0.62 USD. See more details about Xilio Therapeutics, Inc. earnings.
Yes, you can track Xilio Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
XLO stock has fallen by 1.54% compared to the previous week, the month change is a 96.62% rise, over the last year Xilio Therapeutics, Inc. has showed a 58.58% decrease.
XLO net income for the last quarter is −17.66 M USD, while the quarter before that showed −16.75 M USD of net income which accounts for −5.42% change. Track more Xilio Therapeutics, Inc. financial stats to get the full picture.
Today Xilio Therapeutics, Inc. has the market capitalization of 45.40 M, it has increased by 24.32% over the last week.
No, XLO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, XLO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Xilio Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 73.00 employees. See our rating of the largest employees — is Xilio Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Xilio Therapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Xilio Therapeutics, Inc. stock shows the sell signal. See more of Xilio Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Xilio Therapeutics, Inc. future price: according to them, XLO price has a max estimate of 6.00 USD and a min estimate of 5.00 USD. Read a more detailed Xilio Therapeutics, Inc. forecast: see what analysts think of Xilio Therapeutics, Inc. and suggest that you do with its stocks.